+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cell cycle analysis of the CD133+ and CD133- cells isolated from umbilical cord blood



Cell cycle analysis of the CD133+ and CD133- cells isolated from umbilical cord blood



Clinica Chimica Acta; International Journal of Clinical Chemistry 343(1-2): 173-178



Umbilical cord blood cells (stem/progenitor cells) exhibit high proliferative capacities leading to a large expansion of cells in appropriate cell culture conditions. The aim of this study was to evaluate by flow cytometry the cycling status of CD133+ and CD133- cells depending on various culture conditions, such as sera, stem cell factor (SCF), interleukin 3 (IL-3) and interleukin 6 (IL-6). An immunomagnetic system was used for cell separation. CD133+ and CD133- cells were seeded in Iscove's Modified Dulbecco's Medium (IMDM) with different serum concentrations and were stimulated with SCF (100 ng/ml), IL-3 (50 ng/ml) and IL-6 (50 ng/ml). Our experiments demonstrated that immediately after separation, 96.75+/-0.58% of CD133+ cells and 97.04+/-1.76% of CD133- cells were in G0/G1-phase, while 2.02+/-0.38% and 0.88+/-0.52% were in the S-phase, respectively. Our data documented that CD133+ cells are more active than CD133- cells after the first week of cultivation (p<0.01). Statistically significant difference was found for CD133+ cells vs. CD133- cells after second week of cultivation in G0/G1- and S-phases under all tested conditions. A combination of 12.5% FCS+12.5% HS yielded the highest cell expansion for CD133+ cells; this was concomitant with highest percentage of S-phase and G2M-phase. Our data show that the medium with 25% HS was the best for cell expansion and cycling of the CD133- cells for the first week, followed by the 12.5% FCS+12.5% HS. After 2 weeks of cultivation, obviously 12.5% HS and 12.5% FCS+12.5% HS exhibited similar S-phase amounts in CD133- cells. A decrease of HS concentrations seemed to stimulate CD133- cells' S-phase after the second week. Our data indicate that the source and the concentration of the serum used for cultivation have an impact on both cell populations: CD133+ cells are most comfortable with a combination of FCS and HS; CD133- cells prefer media-containing HS. Cell cycle status may be an important factor for defining cultivation strategies for stem cell expansion.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011836506

Download citation: RISBibTeXText

PMID: 15115691

DOI: 10.1016/j.cccn.2004.01.023


Related references

Cell cycle analysis of the CD133(+) and CD133(-) cells isolated from human colorectal cancer. Journal of Cancer Research and Therapeutics 8(3): 399-403, 2013

Umbilical cord blood cells CD133+/CD133- cultivation in neural proliferation media differentiates towards neural cell lineages. Archives of Medical Research 42(7): 555-562, 2011

CD133 immunomagnetic separation: effectiveness of the method for CD133(+) isolation from umbilical cord blood. CytoTherapy 14(6): 701-706, 2012

Paracrine proangiopoietic effects of human umbilical cord blood-derived purified CD133+ cells--implications for stem cell therapies in regenerative medicine. Stem Cells and Development 22(3): 422-430, 2013

CD133+CD34+ and CD133+CD38+ blood progenitor cells as predictors of platelet engraftment in patients undergoing autologous peripheral blood stem cell transplantation. Transfusion and Apheresis Science 46(3): 239-244, 2012

Differentiation of human umbilical cord blood CD133+ stem cells towards myelo-monocytic lineage. Clinica Chimica Acta; International Journal of Clinical Chemistry 343(1-2): 85-92, 2004

Umbilical cord blood-selected CD133(+) cells exhibit vasculogenic functionality in vitro and in vivo. CytoTherapy 12(1): 67-78, 2010

Changes of differentiation and gene expression of CD133+ cells in human umbilical cord blood induced by SCF and bFGF. Zhongguo Shi Yan Xue Ye Xue Za Zhi 18(1): 146-150, 2010

Endolyn (CD164) modulates the CXCL12-mediated migration of umbilical cord blood CD133+ cells. Blood 109(5): 1825-1833, 2007

Are CD133 and CD271 useful in positive selection to enrich umbilical cord blood mesenchymal stem cells?. Zhongguo Shi Yan Xue Ye Xue Za Zhi 18(5): 1286-1291, 2010

The High Yield Expansion and Megakaryocytic Differentiation of Human Umbilical Cord Blood CD133(+) Cells. Cell Journal 13(3): 173-178, 2011

The cross-talk between ROS and p38MAPKα in the Ex Vivo expanded human umbilical cord blood CD133(+) cells. Journal of Huazhong University of Science and Technology. Medical Sciences 31(5): 591, 2011

Expansion of CD133(+) Umbilical Cord Blood Derived Hematopoietic Stem Cells on a Biocompatible Microwells. InternationalJournalofHematology-OncologyandStemCellResearch7(1):9, 2013

CD45+/CD133+ positive cells expanded from umbilical cord blood expressing PDX-1 and markers of pluripotency. Cell Biology International 34(8): 783-790, 2010

Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia. International Journal of Radiation Oncology Biology Physics 67(1): 1-5, 2007